Michael Ainsworth

Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity

J. Barnhill, E. Milner, Michael Ainsworth, 2020 .

Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins

Michael Ainsworth, D. Bookstaver, Melinda M Gleaton, 2022, Journal of clinical pharmacy and therapeutics.

A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations

Michael Ainsworth, D. Bookstaver, Erin Milner, 2022, American Journal of Cardiovascular Drugs.

The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data

Brian Craft, David Haussler, John Black, 2014, Database J. Biol. Databases Curation.

Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases

E. Milner, Michael Ainsworth, D. Rêgo, 2021, Frontiers in Microbiology.

When are Deep Networks really better than Decision Forests at small sample sizes, and how?

Carey E. Priebe, Joshua T. Vogelstein, Florian Engert, 2021, 2108.13637.

When are Deep Networks really better than Random Forests at small sample sizes? pdf

Joshua T. Vogelstein, Sambit Panda, Haoyin Xu, 2021, ArXiv.